Azatoxin derivatives with potent and selective action on topoisomerase II

This publication has 17 references indexed in Scilit:

• Topoisomerase II Inhibition and Cytotoxicity of the Anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute Preclinical Antitumor Drug Discovery Screen
  JNCI Journal of the National Cancer Institute, 1994
• Molecular mechanism of colchicine action: Induced local unfolding of .beta.-tubulin
  Biochemistry, 1993
• Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent
  Biochemical Pharmacology, 1993
• Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells
  Biochemical and Biophysical Research Communications, 1992
• Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II
  Journal of Medicinal Chemistry, 1991
• Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines
  JNCI Journal of the National Cancer Institute, 1991
• Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide
  European Journal of Cancer and Clinical Oncology, 1990
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II
  Biochemistry, 1986
• Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship
  Biochemistry, 1984